SCHEMBL16332134

SCHEMBL16332134

CNc1nc2cnc(Nc3ccccc3)cc2n1Cc1ccc(OC)c(OC)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 3/20 0.52
▸ CYP1A2 P05177 2/20 0.52
▸ CYP3A4 P08684 2/20 0.52
▸ CYP2C9 P11712 2/20 0.52
▸ CYP2C19 P33261 2/20 0.52
▸ CYP2D6 P10635 1/20 0.52
▸ LMNA P02545 4/20 0.48
▸ TSHR P16473 2/20 0.46
▸ MAPK1 P28482 2/20 0.46
▸ PDGFRB P09619 1/20 0.46
▸ PDGFRA P16234 1/20 0.46
▸ HTT P42858 2/20 0.45
▸ CSF1R P07333 7/20 0.44
▸ THRB P10828 1/20 0.44
▸ ALDH1A1 P00352 2/20 0.42
▸ TDP1 Q9NUW8 1/20 0.42
▸ MAPT P10636 3/20 0.42
▸ MEN1 O00255 2/20 0.42
▸ TP53 P04637 2/20 0.42
▸ KMT2A Q03164 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16331960 0.92 CSF1R (0.46) SMN1; SMN2CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL16332395 0.91 LMNA (0.47) SMN1; SMN2CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL16332494 0.91 LMNA (0.47) SMN1; SMN2CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL16332551 0.90 SMN1; SMN2 (0.43) SMN1; SMN2CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL16331586 0.90 SMN1; SMN2 (0.43) SMN1; SMN2CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL16332658 0.90 PDGFRB (0.50) SMN1; SMN2CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL16332223 0.89 SMN1; SMN2 (0.44) SMN1; SMN2CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL16331531 0.89 CSF1R (0.47) SMN1; SMN2CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL16332479 0.87 KIF11 (0.44) SMN1; SMN2CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL16331723 0.87 BRAF (0.43) SMN1; SMN2CYP1A2CYP3A4CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2818472-A1 Imidazo[4,5-c]pyridine and pyrrolo[3,2-c]pyridine compounds as G-protein-coupled receptor kinase 5 (GRK5) modulators Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2014-12-31 — — EP claimed
EP-2818472-A1 Imidazo[4,5-c]pyridine and pyrrolo[3,2-c]pyridine compounds as G-protein-coupled receptor kinase 5 (GRK5) modulators Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2014-12-31 — — EP disclosed
Send feedback